Discover how dopamine’s unexpected role in breaking down harmful plaques could revolutionize Alzheimer's treatment and ...

Researchers challenge everything we know about Alzheimer's disease with shocking new findings about amyloid beta protein's ...

Fenamate NSAIDs inhibit the NLRP3 inflammasome and 2 protect against Alzheimer’s disease in rodent models, published in the journal Nature Communications. DOI: 10.1038/NCOMMS12504 Please note, this ...

Many, including Alzheimer's disease, are treatable. Others, such as depression, thyroid problems, severe nutritional deficiency, or medication interaction, may be reversible. Patients who are ...

New expensive but disease-modifying treatments are expected to foster Alzheimer’s disease market growth globally, according ...

(“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's disease ...

Once daily oral administration of blarcamesine meaningfully slowed clinical decline in early Alzheimer's disease ... a novel treatment that could be complementary or an alternative to injectable ...